Keywords: جهش BRCA; Preimplantation genetic diagnosis (PGD); BRCA mutation; Professionals; Awareness; Knowledge; Acceptability;
مقالات ISI جهش BRCA (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: جهش BRCA; BRCA mutation; Breast neoplasms; Metastases; Ovarian neoplasms; Tumor markers;
Keywords: جهش BRCA; Ovarian cancer; BRCAness; Homologous recombination; Platinum; PARP inhibitor; Alkylating agents; HRness; BRCA mutation;
Keywords: جهش BRCA; BRCA mutation; breast cancer; genetics; panel testing
Keywords: جهش BRCA; Breast cancer; Young age; Triple-negative subtype; BRCA mutation; ACOSOG; American college of surgeons oncology group; BCSS; breast cancer-specific survival; BCT; breast-conserving therapy; CI; confidence interval; CBC; contralateral breast cancer; CPM; c
Self-compassion, physical fitness and climacteric symptoms in oophorectomized BRCA1/2 mutation carriers
Keywords: جهش BRCA; BRCA mutation; Self-compassion; Climacteric symptoms; Risk-reducing salpingo-oophorectomy; Physical fitness;
Nipple-sparing bilateral prophylactic mastectomy and immediate reconstruction with TiLoop® Bra mesh in BRCA1/2 mutation carriers: A prospective study of long-term and patient reported outcomes using the BREAST-Q
Keywords: جهش BRCA; Nipple-sparing mastectomy (NSM); Prophylactic mastectomy; TiLoop; BRCA mutation; Subcutaneous breast reconstruction;
Emerging therapeutic modalities of PARP inhibitors in breast cancer
Keywords: جهش BRCA; PARPi; Platinum; BRCA mutation; Breast cancer; Maintenance;
Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer
Keywords: جهش BRCA; Ovarian cancer; PARP inhibitor; Rucaparib; HRD; BRCA mutation;
Perfil de pacientes con mutación BRCA y cáncer de mama
Keywords: جهش BRCA; Cáncer de mama heredofamiliar; Mutación BRCA; CirugÃas reductoras de riesgo; Subtipos moleculares; Marcadores inmunohistoquÃmicos; Hereditary breast cancer; BRCA mutation; Risk-reducing surgeries; Molecular subtypes; Immunohistochemical biomarkers;
Design, synthesis and biological activity of novel molecules designed to target PARP and DNA
Keywords: جهش BRCA; PARP inhibitors; BRCA mutation; Synthetic lethality; DNA damage; Bis-targeting;
Clinical outcomes of female breast cancer according to BRCA mutation status
Keywords: جهش BRCA; Breast cancer; Breast cancer recurrence; BRCA mutation; Second primary cancer; Mortality;
Relevance of DNA damage repair in the management of prostate cancer
Keywords: جهش BRCA; Prostate cancer; DNA-repair gene defects; BRCA mutation; PARP inhibitor; Immunotherapy;
Nipple-Sparing Mastectomy and Its Application on BRCA Gene Mutation Carrier
Keywords: جهش BRCA; BRCA mutation; Breast neoplasms; Hereditary breast; Mastectomy; Ovarian cancer syndrome;
Sexual activity and functioning after risk-reducing salpingo-oophorectomy: Impact of hormone replacement therapy
Keywords: جهش BRCA; Risk-reducing salpingo-oophorectomy; BRCA mutation; Controls; Sexual activity and functioning; Hormone replacement therapy
Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review
Keywords: جهش BRCA; Probability; Epithelial ovarian cancer; BRCA mutation; Genetic testing; Referral;
Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review
Keywords: جهش BRCA; Serous intraepithelial carcinoma; STIC; BRCA mutation; Risk reducing salpingo-oophorectomy;
Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: Patients' and professionals' perspectives
Keywords: جهش BRCA; BRCA mutation; Ovarian cancer; Risk-reducing strategy; Patients' perspectives; Professionals' perspectives;
Clinical relevance of normal and tumour cell radiosensitivity in BRCA1/BRCA2 mutation carriers: A review
Keywords: جهش BRCA; Breast cancer; BRCA mutation; Radiation therapy; Breast conserving therapy; Radiosensitivity; Outcome;
Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: A critical review of the literature
Keywords: جهش BRCA; Diagnostic radiation; Radiotherapy; Breast cancer; BRCA mutation; Carcinogenicity;
Women In Steady Exercise Research (WISER) Sister: Study design and methods
Keywords: جهش BRCA; Breast cancer; Exercise; BRCA mutation; MR imaging; Sex hormones;
Le cancer du sein triple-négatif. Le triple-négatif est fréquent chez les patientes mutées : comment ne pas le rater ? Comment le caractériser ? De manière plus générale, l'imagerie peut-elle orienter vers le diagnostic histologique ?
Keywords: جهش BRCA; Sein; Cancer triple-négatif; Mammographie; Ãchographie; IRM; Mutation BRCA; Breast; Triple-negative breast neoplasm; Mammography; Ultrasound; MRI; BRCA mutation;
BRCA1/2 mutation carriers are potentially at higher cardiovascular risk
Keywords: جهش BRCA; BRCA mutation; Cardiovascular disease; Risk-reducing salpingo-oophorectomy; Menopause; Cardio-oncology;
Performance of BOADICEA and BRCAPRO genetic models and of empirical criteria based on cancer family history for predicting BRCA mutation carrier probabilities: A retrospective study in a sample of Italian cancer genetics clinics
Keywords: جهش BRCA; Breast cancer; Risk assessment; Genetic testing clinical criteria; BRCA mutation; Genetic models;
Particularités de l'imagerie des cancers du sein chez les femmes jeunes et mutées
Keywords: جهش BRCA; Cancer du sein; Femme jeune; Imagerie; Mutation; Breast cancer; Young women; Imaging; BRCA mutation;
The Management of Early-Stage and Metastatic Triple-Negative Breast Cancer
Keywords: جهش BRCA; Breast cancer; Triple negative; Chemotherapy; Targeted agents; Radiation; BRCA mutation;
The management of menopausal symptoms in breast cancer survivors: A case-based approach
Keywords: جهش BRCA; Breast cancer; BRCA mutation; Menopausal symptoms; Treatment; Hormone replacement therapy
Risk factors associated with the occurrence of breast cancer after bilateral salpingo-oophorectomy in high-risk women
Keywords: جهش BRCA; Hereditary predisposition; BRCA mutation; Bilateral salpingo-oophorectomy; Familial breast cancer; Prophylactic risk-reducing surgery;
La cancérogenèse ovarienne : théories actuelles et passées
Keywords: جهش BRCA; Cancérogenèse ovarienne; Dysplasie ovarienne; Annexectomie prophylactique; Ovulation incessante; Mutation BRCA; P53Ovarian carcinogenesis; Ovarian dysplasia; Prophylactic oophorectomy; Incessant ovulation; BRCA mutation; p53
Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube
Keywords: جهش BRCA; Fallopian tube cancer; Prevalence; BRCA mutation
Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation
Keywords: جهش BRCA; Fallopian tube cancer; Risk factors; BRCA mutation
Disparities in BRCA testing: when insurance coverage is not a barrier
Keywords: جهش BRCA; BRCA mutation; Genetic testing; Disparities
Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer
Keywords: جهش BRCA; Ovarian dysplasia; Ovarian cancer; BRCA mutation; Ovulation induction
PCR-free mutation detection of BRCA1 on a zip-code microarray using ligase chain reaction
Keywords: جهش BRCA; Mutation detection; Ligase chain reaction; Zip-code microarray; BRCA mutation
Dysplasie épithéliale ovarienne : mythe ou réalité ? Revue de la littérature
Keywords: جهش BRCA; Stérilité; Dysplasie ovarienne; Stimulation de l’ovulation; Annexectomie prophylactique; Mutation BRCA; Cancer de l’ovaire; Carcinogenèse ovarienneInfertility; Ovarian dysplasia; Ovulation stimulation; Prophylactic oophorectomy; BRCA mutation; Ovarian car
Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish Woman with primary breast and ovarian cancer
Keywords: جهش BRCA; Ashkenazi Jewish female; BRCA mutation; ovarian carcinoma
Risk and risk assessment for breast cancer: Molecular and clinical aspects
Keywords: جهش BRCA; BRCA mutation; Breast cancer; Chemoprevention; Risk assessment; Risk calculation